Skewing patterns of 21 individual VB subfamilies in AA.

(A) Healthy controls (n = 19). (B) New AA (n = 15). (C) Patients with AA with HLA-DR2 (n = 9). (D) Patients with AA with HLA-A2 (n = 7). * P < .05; ** P < .01; ***P < .001. All the significance levels were calculated in comparison with healthy controls.